The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

Pharma

MNCs are in awe of Serum Institute’s clout in vaccines. It’s now on the cusp of raising the bar.

MNCs are in awe of Serum Institute’s clout in vaccines. It’s now on the cusp of raising the bar.
MNCs are in awe of Serum Institute’s clout in vaccines. It’s now on the cusp of raising the bar.
BCCL
Doses of the potential Covid-19 vaccine manufactured by the Serum Institute of India (SII) has arrived at the Bharti hospital and medical college for phase-2 human clinical trials.

Synopsis

The Pune-based vaccine manufacturer has a track record of taking up the challenge whenever there was a need to deliver vaccines on humanitarian grounds rather than merely for business or profits. Undaunted by strategic and regulatory hurdles, it has pledged to ensure equitable distribution of vaccines against Covid-19 once they are ready for release.

When was the last time anyone heard of a global company giving up on plans to do business in India, wary of a rival several times smaller in size? Not many know of it, but back in 2009, that’s how a David-versus-Goliath scenario played out. A team of about 20 top-deck executives from Swiss pharmaceutical giant Novartis took a chartered plane to India. Their mission was to cut lucrative deals in the vaccines business – either buyouts or long-term
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

To Read the Full Story, Become an ET Prime Member

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Access the exclusive Economic Times stories, Editorial and Expert opinion

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times